Salient Surgical Technologies

I'm also curious. The recruiter I'm working with says that they are focusing on ortho - that its really taking off. I'm wondering if anyone has heard anything about the sucess or failure with the ortho surgeons?
 












ortho guys use orthopat or strykers constavac for blood management along with the 400 year old bovie. good luck.

I am considering Salient but have some questions.

Am I correct in stating that orthopat and constavac both are mechanisms that allow for drainage of blood and then easy re-infusion?

If so, and the Aquamantys will seal the vessels permanently before drainage is needed, why wouldn't they use it?

From what I have gathered, with the Aquamantys the seal will not crack later, where as the Bovie's seal can crack post-op resulting in more sever swelling a drainage in the joint.

Anyone care to chime in?
 












The product works, but orthos don't care all that much. They're used to placing drains and they get decent outcomes, so there's little motivation for them to use a device that, while providing better hemostasis, takes longer to use. If reimbursement is also an issue (not sure about this), then the adoption curve is all the more steep.
 












I am considering Salient but have some questions.

Am I correct in stating that orthopat and constavac both are mechanisms that allow for drainage of blood and then easy re-infusion?

If so, and the Aquamantys will seal the vessels permanently before drainage is needed, why wouldn't they use it?

From what I have gathered, with the Aquamantys the seal will not crack later, where as the Bovie's seal can crack post-op resulting in more sever swelling a drainage in the joint.

Anyone care to chime in?

Dude, thats exactly how it works. i couldnt have said it better myself. Hey, you guys with the glass half empty could learn from this cat... It's amazing what forward thinking can do
 






Nobody listen to this guy, he's an obvious failure who has been misinformed and is not educated... IDIOT!

yep i am an idiot. an idiot who has removed tissuelink and made a killing in blood management selling an equally shitty product. pal take the job, you will be looking again in a year. last poster, see you in hell.
 






Re: Salient Surgical Hiring

To whomever is reading this, don't even waste your time here. I interviewed out west with a guy named Adam King and it was a total waste of time. This guy could not make up his mind on who he wanted, or make any other kind of decision for that matter . Upon research of this company I found that their products are VERY uncompetitive and most of what we discussed was a stretch. Being a rep in the business, if I had a piece of advice for you, I'd say keep looking. Thanks.
 






Bovie has their new seer technology for cutting and sealing vessels. It will be interesting to see what Salient will do to compete. Also, does anyone have knowledge of their Bipolar device for ortho and spine. It will be released very soon and their business model is exactly like Salients. That is the company you should check out right now. The product is under the Boss tissue sealing name. Any thoughts would be gladly accepted.
 






The technology is not new. It is a sintered metal electrode instead of one made by traditional manufacturing means. The clinical advantages of a sintered electrode, if any, are not readily evident and any benefit may be in the form of manufacturing costs and / or working around competiting electrode IP.

It is essentially the same device Salient had back when it was called Tissuelink in that the device connects to an IV bag and generator rather than an all-in-one piece of capital that Salient is currently selling. If you like having a device and system that automatically adjusts generator power and saline flow, then the Salient capital investment is worth it. If you don't mind adjusting power and flow (either through an IV pump or roller clamp) separately, then the SEER is just fine.

The VP of R&D at Bovie was exposed to the Salient technology in the early 00s when he was at BSX. Boive purchased the electrode IP in May 2008, the same month that their new VP came on board.

http://www.boston.com/business/ticker/2008/05/bovie_will_buy.html

Bovie's saline mediated RF works the same as Salient's. Clinical efficacy of both products is largely predicated on the generator power settings and the associated flow of saline. Vessels over 3mm in diameter (and sometimes less) cannot be sealed without accompanying mechanical compression.
 






Great information on the development of Bovie and their new technology. I am sure we will see some market shifts and company dynamics change. It will be hard to keep the exuberant price point on the Salient products when another is half the price. Bovie has taken some large accounts from Salient with the seer device and will release the bipolar version first quarter. May be an attitude adjustment for some individuals who somehow made it up top. Your info. is solid, thanks.
 






This product creates a problem that is not really an issue. The areas that are treated need not be under normal circumstance so its an expensive OR toy. If your doctor thinks he's Lee Marvin then it could be for him. Turn and burn sums it up, they hire and fire and have let some great staff go.
 












The product works, but orthos don't care all that much. They're used to placing drains and they get decent outcomes, so there's little motivation for them to use a device that, while providing better hemostasis, takes longer to use. If reimbursement is also an issue (not sure about this), then the adoption curve is all the more steep.

This about sums it up. How much blood are you going to save by using this product when drains show minimal post op?

A waste of time and money